Blood Pressure

Data from the PROPEL trial revealed that a 24-month intensive lifestyle intervention initiated in the primary care setting improved risk factors for patients with obesity. It was the top story in cardiology last week.

In a Mendelian randomization study, elevated systolic BP, diastolic BP and pulse pressure were each associated with increased risk for atrial fibrillation.

Phosphate binder lanthanum carbonate increased systolic blood pressure in patients with chronic kidney disease, leading researchers to suggest the drug “may reduce gastrointestinal absorption of antihypertensive medications.”

Although higher systolic blood pressure at baseline was associated with eGFR decline in patients with chronic kidney disease, disease progression may be more accurately predicted when blood pressure is measured over time.

It is safe for patients hospitalized with COVID-19 to continue using renin-angiotensin system inhibitors, researchers reported.

For patients receiving hemodialysis in Taiwan, bisoprolol demonstrated superior safety compared with carvedilol, according to a study of the two beta blockers.

Testing for primary aldosteronism was rare among a cohort of U.S. veterans with treatment-resistant hypertension, yet was associated with higher rates of evidence-based treatment and better longitudinal blood pressure control, data show.

Higher Dietary Approaches to Stop Hypertension, or DASH, diet scores were associated with lower diastolic BP in midpregnancy and lower fetoplacental vascular function in mid- and late pregnancy, researchers reported.

Tailored interventions addressing specific socioeconomic concerns may improve BP control in patients with hypertension, a recent analysis showed. It was the top story in cardiology last week.

BP and hypertension may be associated with risk for white matter lesions in atrial fibrillation but not with large noncortical or cortical infarcts, according to data published in Hypertension.